共 78 条
[1]
Mangin D(2018)International group for reducing inappropriate medication use & polypharmacy (IGRIMUP): position statement and 10 recommendations for action Drugs Aging 35 575-587
[2]
Bahat G(2017)The dangers of polypharmacy in elderly patients JAMA Int Med. 177 1544-571
[3]
Golomb BA(2018)Polypharmacy and adherence among diabetic patients in Greece Consultant Pharmacist 33 562-36
[4]
Turgeon J(2019)Polypharmacy and drug adherence in elderly patients US Pharm 44 33-613
[5]
Michaud V(2018)Costs of medication in older patients: before and after comprehensive geriatric assessment Clin Interv Aging 13 607-519
[6]
Steffen L(2011)Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study Eur J Clin Pharmacol 67 507-ii
[7]
Geitona M(2014)Polypharmacy: a global risk factor for elderly people J Int Oral Health JIOH 6 i-883
[8]
Latsou D(2010)Polypharmacy and combination therapy in the management of hypertension in elderly patients with co-morbid diabetes mellitus Drugs Aging 27 871-144
[9]
Toska A(2018)Polypharmacy and comorbidity status in the treatment of type 2 diabetic patients attending a tertiary care hospital: an observational and questionnaire-based study Perspect Clin Res 9 139-2574
[10]
Saridi M(2018)Drug utilization and factors associated with polypharmacy in individuals with diabetes mellitus in Minas Gerais, Brazil Ciencia Saude Coletiva 23 2565-267